Pages that link to "Q36595143"
Jump to navigation
Jump to search
The following pages link to Extended-release intramuscular naltrexone (Q36595143):
Displaying 10 items.
- Sustained-Release Naltrexone For Opioid Dependence (Q24243205) (← links)
- Medications for unhealthy alcohol use: across the spectrum (Q27690692) (← links)
- College student receptiveness to various alcohol treatment options (Q33638015) (← links)
- Opioid Addiction: Social Problems Associated and Implications of Both Current and Possible Future Treatments, including Polymeric Therapeutics for Giving Up the Habit of Opioid Consumption. (Q33747985) (← links)
- Extended-release intramuscular naltrexone in alcohol dependence in adults: profile report (Q36693022) (← links)
- Encapsulation of exenatide in poly-(D,L-lactide-co-glycolide) microspheres produced an investigational long-acting once-weekly formulation for type 2 diabetes (Q37900626) (← links)
- Clinical implications of exenatide as a twice-daily or once-weekly therapy for type 2 diabetes (Q37929511) (← links)
- Extended-release intramuscular naltrexone (VIVITROL®): a review of its use in the prevention of relapse to opioid dependence in detoxified patients (Q38135704) (← links)
- Thermosensitive Pluronic® hydrogel: prolonged injectable formulation for drug abuse (Q42175771) (← links)
- Impact of Treatment With Intramuscular, Injectable, Extended-Release Naltrexone on Counseling and Support Group Participation in Patients With Alcohol Dependence (Q42730392) (← links)